Alkermes Receives Refusal to File Letter From FDA for ALKS 5461BenzingaDUBLIN, April 2, 2018 /PRNewswire/ -- Alkermes plc (NASDAQ:ALKS) today announced that it received a Refusal to File letter from the U.S.
